JP7746135B2 - Drug volatilizer - Google Patents

Description

The present invention relates to a chemical volatilizer that is attached to an air conditioning vent.

BACKGROUND ART Chemical vaporizers have been provided that are attached to the air outlets of automobile or home air conditioners and electric fans.
One such chemical volatilizer has been disclosed that includes a container filled with liquid chemical (aromatic components), a suction member that is located from the opening of the container to the inside of the container and sucks up the chemical and volatilizes it into the air through the opening, and a clip-type attachment that supports the container and can be detachably attached to the air outlet (see Patent Document 1).

JP 2016-166046 A

In the above-mentioned conventional chemical vaporizer, when the chemical in the container volatilizes and disappears, the empty container must be replaced with a new one and used.
This requires a series of replacement procedures, including removing the attachment attached to the air outlet, removing the empty container from the attachment, attaching a new container filled with the drug to the attachment, and then reattaching the attachment to the air outlet.
Among these replacement operations, the task of removing the empty container from the fixture and the task of attaching a new container to the fixture are time-consuming tasks that require the use of both hands, such as holding the fixture with one hand and the container with the other, and therefore there is room for improvement in terms of usability.
The present invention has been devised in view of the above circumstances, and an object of the present invention is to provide a drug volatilizer that can be replaced easily and reliably and is easy to use.

In order to achieve the above-mentioned object, the present invention provides a drug volatilization device comprising a drug container in which a drug is sealed, and a case for housing the drug container, the case being attached to an air outlet of an air conditioner for use, the case comprising a container body having a storage section for housing the drug container and attached to the air outlet, and a lid body connected to the container body so as to be swingable between a closed position that closes the storage section and an open position that opens the storage section, the lid body having a viewing window through which the drug sealed in the drug container can be seen when positioned in the closed position, and the storage section is configured so that the drug container can be removed from and inserted into the container body when the lid body is in the open position.
The present invention is also characterized in that the container body is provided with a clip that can be detachably attached to a wind direction plate arranged at the air outlet.
Furthermore, the present invention is characterized in that when the container body is attached to the air outlet, the container body has a rear wall facing the air outlet and having an air intake port, and when the container body is attached to the air outlet, the air blowing direction at the air outlet is defined as the front of the case, the air blowing direction and the opposite direction to the air blowing direction are defined as the front-to-back direction of the case, and the horizontal direction perpendicular to the front-to-back direction is defined as the left-to-right direction of the case, the container body has a bottom wall that protrudes forward from the lower end of the rear wall, and the storage section is configured to include a support wall that is provided on the container body above the bottom wall and forwardly spaced from the rear wall and supports the drug storage body so that it can be inserted and removed from below and from both sides of the front-to-back direction of the case and both sides of the left-to-right direction of the case.
The present invention also features that the drug container comprises a container body formed of a transparent material that is impermeable to the drug, having an outer peripheral flange extending in a frame-like shape on a plane and a bulging portion that bulges out hollowly from the inside of the outer peripheral flange, a sealing sheet formed of a material that allows the drug to pass through and attached to the outer peripheral flange, closing the bulging portion and sealing the drug inside the bulging portion, and a release film formed of a material that is impermeable to gas and the drug and releasably attached to the sealing sheet, and the drug container is supported by the support wall with the sealing sheet or the release film facing the rear wall.
The present invention is also characterized in that the support wall supporting the drug container from below is composed of a bulge support wall that supports the bulge from below, and the support walls supporting the drug container from both sides of the front-to-back direction of the case are composed of a pair of front-to-back front support walls that abut the outer peripheral flanges located on both the left and right sides of the bulge from the front of the case, and a rear-to-back support wall that abuts the drug container from the rear of the case, and the pair of front-to-back support walls are arranged so as to be able to abut against both sides of the bulge in the left-to-right direction from the outside of the case in the left-to-right direction, and the pair of front-to-back support walls constitute support walls that support the drug container so that it can be inserted and removed from both sides of the left-to-right direction of the case.
The present invention is also characterized in that, when the lid body is positioned in the closed position, it has a front wall that faces the rear wall and has the viewing window formed therein, and an upper wall that protrudes rearward from the upper end of the front wall, faces the bottom wall, and has its tip joined to the upper end of the rear wall, and the upper wall is provided with a regulating portion that regulates the upward movement of the drug container supported by the support wall.
The present invention is also characterized in that the case has a peripheral wall that connects the periphery of the rear wall and the periphery of the front wall when the lid is positioned in the closed position and forms an air outlet, the bottom wall and the top wall form part of the peripheral wall, and when the lid is positioned in the closed position, a gap is secured between the drug container supported by the support wall and the rear wall to allow air to flow, and a gap is secured between the periphery of the drug container and the peripheral wall to allow air to flow around the entire periphery of the drug container.
The present invention is also characterized in that when the cover is positioned in the closed position, a gap is secured between the front wall and the outer flange that allows air to flow and communicates with the viewing window.
The present invention is also characterized in that the clip is provided approximately in the center of the rear wall, and an adjustment member that changes the opening area of the air intake is arranged on the rear wall so as to be rotatable around the clip.

According to the present invention, the lid body can be easily swung from the closed position to the open position and from the open position to the closed position with one hand, and when the lid plate is in the open position, the medicine container can be easily picked up with one hand and removed upward from the storage section and inserted into the storage section from above.
Therefore, the medicine container can be easily replaced, which is advantageous in increasing the commercial value of the medicine volatilizer, enhancing the willingness to purchase the medicine volatilizer, and increasing the amount of medicine volatilizer purchased.
In addition, according to the present invention, by providing a clip on the container body, the drug container can be replaced without removing the drug volatilizer from the air deflector, which is advantageous in increasing the commercial value of the drug volatilizer and increasing the amount of drug volatilizer purchased.
Furthermore, according to the present invention, the container body is configured to include support walls that support the drug container so that it can be inserted and removed from below, both sides of the case in the front-to-back direction, and both sides of the case in the left-to-right direction.Therefore, by inserting the drug container from above the storage section, the drug container can be easily positioned relative to the storage section, which improves the usability of the drug volatilizer, increases the commercial value of the drug volatilizer, increases purchasing desire for the drug volatilizer, and is advantageous in increasing the amount of drug volatilizer purchased.
Furthermore, according to the present invention, when the drug volatilizer is in use, the drug container is supported by a support wall with the sealing sheet facing the rear wall, so that air from the outlet that passes through the air intake in the rear wall hits the sealing sheet, which is advantageous in effectively exerting the aromatic and deodorizing effects of the drug volatilizer.
In addition, according to the present invention, the support wall that supports the drug container from below is composed of a support wall for the bulge portion that supports the bulge portion from below, so when the drug container is inserted into the support wall, the receiving wall for the bulge portion functions as a marker for where to position the bulge portion, which is advantageous for smooth insertion of the drug container into the support wall.
In addition, the wall portion that positions the case of the drug container in the front-to-back direction is composed of a pair of front-to-back front support walls that abut from the front of the case against the outer flanges located on both the left and right sides of the bulge portion, which is advantageous in simplifying the structure of the support walls and reducing the cost of the case.
Furthermore, according to the present invention, a regulating section is provided on the upper wall of the lid body to regulate the upward movement of the drug container supported by the support wall, which is advantageous in stabilizing the posture of the drug container supported by the support wall and contained in the container section when the lid body is in the closed position, and is advantageous in increasing the commercial value of the drug volatilizer.
Furthermore, according to the present invention, a gap is secured between the drug container supported by the support wall and the rear wall, allowing air to flow, and a gap is secured between the periphery of the drug container and the peripheral wall, allowing air to flow around the entire periphery of the drug container. This is advantageous in allowing more air from the air outlet to enter the inside of the case through the air intake, which is advantageous in fully exerting the effects of the drug, such as its aromatic and deodorizing effects, and is advantageous in increasing the commercial value of the drug volatilizer, increasing purchasing desire for the drug volatilizer, and increasing the amount of drug volatilizer purchased.
Furthermore, according to the present invention, a gap is secured between the front wall and the outer peripheral flange, allowing air to circulate through the viewing window, so that air containing the vaporized chemical can be blown out through the viewing window, which is advantageous in allowing more air from the air outlet to be taken into the inside of the case through the air intake.For example, if an air freshener or deodorizer is used as the chemical, this is advantageous in allowing the aromatic or deodorizing effect to be fully exerted, which is advantageous in increasing the commercial value of the chemical volatilizer, increasing purchasing desire for the chemical volatilizer, and increasing the amount of chemical volatilizer purchased.
Furthermore, according to the present invention, an adjustment member is provided so that the opening area of the variable air intake can be changed, so that, according to the needs of the purchaser of the chemical volatilizer, for example, if an air freshener or deodorizer is used as the chemical, the aromatic or deodorizing effect can be adjusted to be stronger or weaker, which is advantageous in increasing the commercial value of the chemical volatilizer, enhancing purchasing desire for the chemical volatilizer, and increasing the amount of chemical volatilizer purchased.
In addition, according to the present invention, the clip is positioned approximately in the center of the rear wall, and the adjustment member is arranged so that it can rotate around the clip. Therefore, when viewed from the front of the drug volatilizer, most of the adjustment member is hidden by the case, which enhances the design of the drug volatilizer with the function of adjusting the opening area of the variable air intake, increases purchasing desire for the drug volatilizer, and is advantageous in increasing the amount of drug volatilizers purchased.

FIG. 1 is a perspective view of a medicine volatilizer in use. FIG. 2 is a front view of the medicine volatilizer. FIG. 3 is a view taken along an arrow A in FIG. 2 . FIG. 3 is a view taken along the arrow B in FIG. 2 . FIG. 2 is a plan view of the medicine volatilization device. FIG. 2 is a bottom view of the medicine volatilization device. A side view of the medicine volatilizer with the case swung to the open position. 1 is an oblique view of a medicine volatilizer with the case swung to the open position. FIG. 10 is a perspective view of the case in a state where the case is swung to an open position and the medicine container is removed. FIG. FIG. 2 is a perspective view of the container body as seen from the front. FIG. 2 is a perspective view of the container body as seen from the front. FIG. 2 is a perspective view of the container body as seen from the rear. FIG. 10 is a perspective view of the container body from the rear with the adjustment member removed. FIG. 2 is a front view of the container body with the adjustment member removed. FIG. 10 is a rear view of the container body with the adjustment member removed. FIG. 14 is a view taken along an arrow A in FIG. 13 . FIG. 14 is a view taken along the arrow B in FIG. 13 . FIG. 2 is a plan view of the container body with the adjustment member removed. FIG. 10 is a bottom view of the container body with the adjustment member removed. An explanatory diagram of the adjustment member, (A) shows a state in which four openings of the adjustment member are connected to the variable air intake, (B) shows a state in which three openings of the adjustment member are connected to the variable air intake, and (C) shows a state in which two openings of the adjustment member are connected to the variable air intake. 1A is a perspective view of the clip, and FIG. 1B is a side view of the clip. 1A is a front view of the adjustment member, and FIG. 1B is a side view of the adjustment member. FIG. FIG. 24 is a view taken along the arrow A in FIG. 23. FIG. 24 is a view taken along arrow B in FIG. 23. FIG. FIG. FIG. FIG. 1A is a perspective view of the medicine container, FIG. 1B is a front view of the medicine container, and FIG. 1C is a side view of the medicine container.

Next, an embodiment of the medicine volatilizing device of the present invention will be described.
A medicine volatilizer 10 shown in FIGS. 1 to 9 includes a medicine container 12 and a case 14 .
First, the medicine container 12 will be described with reference to Fig. 30. In all the drawings, thin lines are used to represent the three-dimensional shape so that the three-dimensional shape can be easily understood.
The medicine container 12 includes a container body 16 , a sealing sheet 18 , a release film 20 , and a medicine 22 .

The container body 16 is formed of a transparent material that is impermeable to gas (air) and the chemical 22. The type of material varies depending on the type of volatile chemical 22 to be contained, but various conventionally known materials such as polypropylene, polyester, and polyvinyl chloride can be used.
The container body 16 has an outer peripheral flange 1602 extending on the same plane, a bulge 1604 provided on the inside of the outer peripheral flange 1602, and a tab 1606 shown in imaginary lines provided on the outer peripheral flange 1602.
The tab 1606 is connected to a bulging base 1602A provided on the outer peripheral flange 1602 via a cut line.
In this embodiment, the outer peripheral flange 1602 is provided in the shape of a substantially square frame, and the bulging portion 1604 is provided in the shape of a substantially square pillar from the center of the outer peripheral flange 1602 .
The bulge 1604 has four side surfaces 1604A rising from the inner periphery of the outer flange 1602, and a curved top surface 1604B connecting the tips of the side surfaces 1604A.
When viewed from the front, the top surface 1604B is approximately square with rounded corners, and adjacent side surfaces 1604A are connected by curved surfaces.
The top surface 1604B of the bulge 1604 functions as an indicator for visually checking the remaining amount of the medicine 22.
When the medicine volatilizer 10 is in use, the medicine container 12 may be arranged with the bulging base 1602A positioned at any of the upper, lower, left and right sides.

The sealing sheet 18 extends in a plane and has substantially the same contour as the peripheral flange 1602 including the tab 1606 .
The sealing sheet 18 has a rectangular portion 1802 attached to the peripheral flange 1602 with the same contour as the peripheral flange 1602, a bulging base 1802A of the same shape as the bulging base 1602A of the container main body 16 provided on the rectangular portion 1802, and a tab 1804 connected to the bulging base 1802A via a cut line.
By attaching rectangular portion 1802 of sealing sheet 18 to outer peripheral flange 1602, a medicine containing space 24 is formed between sealing sheet 18 and bulging portion 1604, and medicine 22 is sealed in medicine containing space 24.
The sealing sheet 18 is formed of a material that allows the drug 22 to pass through.
In this embodiment, the sealing sheet 18 is formed of a material that has elasticity that allows the permeation of the drug 22 and is breathable that allows the permeation of gas (air), but it is also possible to use a material that has elasticity that prevents the permeation of gas (air) but allows the permeation of the drug 22.
The material constituting such a sealing sheet 18 varies depending on the type of volatile chemical 22 to be contained, but various conventionally known materials can be used, such as polyethylene, polyurethane, EVA, EVOH, multilayer elastomers containing these, films in which these materials are mixed with fillers such as finely ground silica, clay, zeolite, or laminates of these materials.

The release film 20 is releasably attached to the surface of the sealing sheet 18 opposite to the surface on which the medicine-containing space 24 is located.
The peeling film 20 has a rectangular portion 2002 having the same contour as the rectangular portion 1802 of the sealing sheet 18, a bulging base portion 2002A having the same shape as the bulging base portion 1602A of the container main body 16 provided in the rectangular portion 2002, and a tab 2004 connected to the bulging base portion 2002A.
In the release film 20, no cutting line is provided between the bulging base 2002A and the tab 2004, and the tab 1606 of the container body 16, the tab 1804 of the sealing sheet 18, and the tab 2004 of the release film 20 have the same contour and are attached together.
The release film 20 is made of a material that is impermeable to gas (air) and the drug 22. The material varies depending on the type of volatile drug 22 to be contained, but various conventionally known materials can be used, such as polypropylene, polyester, polyvinyl chloride, films of these materials with metal vapor deposition such as aluminum or metal foil attached thereto, or combinations of these materials.
The rectangular portion 2002 of the release film 20 is releasably attached to the rectangular portion 1802 of the sealing sheet 18 .
A user of the medicine volatilizer 10 pinches the tabs 1606, 1804, and 2004 to peel the release film 20 from the sealing sheet 18. In Figure 30, the medicine container 12 is shown by a solid line in a state in which the release film 20 has been peeled from the sealing sheet 18 by pinching the tabs 1606, 1804, and 2004, and the medicine volatilizer 10 is used by inserting the medicine container 12, from which the release film 20 has been peeled from the sealing sheet 18, into the storage section 36 of the case 14 (see Figures 7 and 8).

The chemical 22 is liquid and volatile.
In this embodiment, the chemical 22 is a fragrance, but the chemical 22 may be, for example, a deodorizer, an insecticide, a fungicide, a bactericide, an insect repellent, a repellent, etc., and the chemical 22 is not limited to a fragrance.
For ease of explanation, the side of the drug container 12 on which the bulging portion 1604 is provided will be referred to as the front side of the drug container 12, the side on which the sealing sheet 18 and the peeling film 20 are provided will be referred to as the back side of the drug container 12, the bulging direction of the bulging portion 1604 will be referred to as the thickness direction of the drug container 12, and the direction perpendicular to the bulging direction of the bulging portion 1604 will be referred to as the width direction of the drug container 12.

Next, the case 14 that accommodates the medicine container 12 so that it can be removed and inserted will be described.
The case 14 comprises a container body 26 shown in Figures 10 to 20, a lid body 28 shown in Figures 23 to 29, a clip 30 shown in Figure 21, and an adjustment member 32 shown in Figure 22, which are made of synthetic resin and molded using a mold.
When the container body 26 is attached to the air outlet 34 (see Figure 1), as shown in Figures 10, 13, 14, and 15, the container body 26 has a rear wall 2602 facing the air outlet 34, and as shown in Figure 23, the lid body 28 has a front wall 2802 that faces the rear wall 2602 when the lid body 28 is in the closed position and has a viewing window 2804 formed therein, and as shown in Figure 1, the case 14 has a peripheral wall 1402 that connects the periphery of the rear wall 2602 and the periphery of the front wall 2802 when the lid body 28 is in the closed position, and forms a first side air outlet 44A (see Figure 3), a second side air outlet 44B (see Figure 4), and a downward air outlet 44C (see Figure 6).

The rear wall 2602 of the container body 26 is the part that is attached to the air outlet 34 (see Figure 1), and the rear wall 2602 has a rear surface 2602A that faces the air outlet 34, as shown in Figures 13 and 15, and a front surface 2602B that is located opposite the rear surface 2602A, as shown in Figure 14.
In the following description, the air blowing direction at the air outlet 34 is defined as the front of the case 14, the air blowing direction at the air outlet 34 and the opposite direction to this air blowing direction are defined as the front-to-back direction of the case 14, and the horizontal direction perpendicular to the front-to-back direction is defined as the left-to-right direction of the case 14.
As shown in FIG. 10, a clip fitting hole 2604 is formed through the center of the rear wall 2602 .
The container 36 for accommodating the medicine container 12 is provided on the front surface 2602B of the rear wall 2602.

As shown in Figures 14 and 15, a pair of variable air intakes 2606 are formed extending in an arc shape on both sides of approximately the upper half of the rear wall 2602, and protruding walls 2608 are provided on both left and right sides of approximately the lower half of the rear wall 2602, protruding in the left-right direction away from the center of the rear wall 2602.
A pair of air intake notches 2610 are formed on both sides of the upper edge of the rear wall 2602, extending in an arc shape.
The lower ends of the pair of air intake recesses 2610 in the extension direction are separated by the upper end of the protruding wall 2608, and the upper ends of the pair of air intake recesses 2610 are separated by a wall portion that stands up from the upper end of the rear wall 2602.
As shown in Figures 13 and 15, on the back surface 2602A of the back wall 2602, a cylindrical upright surface 2612 is provided that stands up from the back surface 2602A along the extension direction of a pair of air intake notches 2610 and follows the contour of the adjustment member 32 described later.

On the rear surface 2602A of the rear wall 2602 where one of the pair of air intake recesses 2610 is provided, an upright surface 2614 that is continuous with the cylindrical upright surface 2612 is provided on the protruding wall 2608.
On the back surface 2602A of the back wall 2602 where the other of the pair of air intake recesses 2610 is provided, the back surface of the protruding wall 2608 is formed as the protruding wall back surface 2608A that is located on the same plane as the back surface 2602A of the back wall 2602.
At the top of this protruding wall back surface 2608A, an upper end wall portion 2616A protruding from the upper end of the protruding wall 2608 that separates the lower end of the other air intake recess 2610 in the extension direction is located, and a lower end wall portion 2616B protrudes from the wall surface of the protruding wall 2608 below the upper end wall portion 2616A.
A rotation operation knob 3208 (see FIG. 20) of the adjustment member 32, which will be described later, is arranged to be swingable between the upper end wall portion 2616A and the lower end wall portion 2616B on the rear surface 2608A of the protruding wall.
As shown in FIGS. 13 to 15, a flexible locking plate 2618 that can be engaged with and disengaged from the cover 28 is provided at the upper end of the center of the rear wall 2602 in the width direction.

As shown in Figures 10 and 11, the container body 26 has a bottom wall 2620 that protrudes forward from the lower edge of the outer periphery of the front surface 2602B of the rear wall 2602, and a pair of lower side walls 2622 that are connected to this bottom wall 2620 and protrude forward from the lower part of the side edges on both the left and right sides of the front surface 2602B of the rear wall 2602.
The upper edges of the pair of lower side walls 2622 are connected to the front surface 2602B of the rear wall 2602, and above the upper edges of the pair of lower side walls 2622 there are air intake recesses 2624 that are open forward and upward.
The bottom wall 2620 and the pair of lower side walls 2622 form part of the peripheral wall 1402 .

Furthermore, the container body 26 has an intermediate upright wall 2626 that rises upward from the protruding end of the bottom wall 2620 and faces the lower part of the rear wall 2602, a bulge support wall 2628 that is provided on the upper edge of the intermediate upright wall 2626 and protrudes forward in an arc shape from the upper edge of the intermediate upright wall 2626, on which the bulge 1604 is placed, a pair of side upright walls 2630 that protrude forward from both the left and right sides of the intermediate upright wall 2626 toward the tips of the lower side walls 2622, and a pair of tip walls 2630A that connect the tips of the pair of side upright walls 2630 to the tips of the pair of lower side walls 2622.
As shown in FIG. 18, when the bottom wall 2620 is viewed from above, a lower cutout 2632 that is open forward is formed by the intermediate upright wall 2626 and a pair of side upright walls 2630 .
The front surface 2602B side of the rear wall 2602 forms the storage section 36 that stores the drug container 12, and the bottom of the storage section 36 is formed by a space surrounded by a bottom wall 2620, a pair of lower side walls 2622, and a pair of intermediate upright walls 2626, and the storage section 36 excluding the bottom is formed open in front of the front surface 2602B of the rear wall 2602.
A support shaft 2634 for connecting the cover body 28 is protruded from the pair of side upright walls 2630 .

As shown in Figure 10, the storage section 36 is configured to include a support wall 38 that is provided on the container body 26 above the bottom wall 2620 and away from the rear wall 2602, and that supports the drug storage body 12 so that it can be inserted and removed from below, both sides of the case 14 in the front-to-back direction, and both sides of the case 14 in the left-to-right direction.
As shown in Figure 3, when the drug container 12 is inserted into the storage section 36, the bulge portion 1604 is placed on the bulge portion support wall 2628, and therefore the support wall 38 that supports the drug container 12 from below is composed of the bulge portion support wall 2628 that supports the bulge portion 1604 from below.
As shown in Figure 10, the support walls 38 that support the drug container 12 from both sides in the front-to-back direction of the case 14 are composed of a pair of front-to-back front support walls 2636 that abut from the front of the case 14 against the outer peripheral flanges 1602 located on both the left and right sides of the bulge portion 1604, and a rear front-to-back support wall 2638 that abuts against the sealing sheet 18 or peel-off film 20 from the rear of the case 14 at the center of the drug container 12 in the left-to-right direction of the case 14, from the lower end of the drug container 12 to the middle part in the up-to-down direction of the drug container 12.

In detail, as shown in FIG. 10, the pair of front support walls 2636 have a thickness in the left-right direction and extend upward from both the left and right sides of the bottom wall 2620 along the intermediate upright wall 2626, and the rear surfaces 2636A of the pair of front support walls 2636 abut against the outer peripheral flanges 1602 located on both the left and right sides of the bulge portion 1604 from the front of the case 14, as shown in FIG. 8.
As shown in Figure 14, the pair of front support walls 2636 in the front-to-rear direction are formed at a height such that their upper ends are positioned on both the left and right sides of the lower part of the bulge portion 1604 when the bulge portion 1604 of the drug container 12 is placed on the bulge portion support wall 2628.
As shown in Figure 10, the upper ends of the pair of front support walls 2636 in the forward/backward direction are formed with curved surfaces 2636B that guide the drug container 12 to the rear surfaces 2636A of the pair of front support walls 2636 in the forward/backward direction when the drug container 12 is inserted into the support wall 38.
The front-rear support wall 2638 has a thickness in the left-right direction and extends upward from the bottom wall 2620 at the center of the width of the front surface 2602B of the rear wall 2602, with its upper end located approximately in the center of the front surface 2602B.
A front surface 2638A of the rear support wall 2638 in the front-rear direction abuts against the sealing sheet 18 or the release film 20 from the rear of the case 14 across the range from the lower end of the medicine container 12 to the middle part of the medicine container 12 in the vertical direction.
An inclined surface 2638B is formed at the upper end of the rear support wall 2638 in the front-rear direction, which guides the medicine container 12 to a front surface 2638A of the rear support wall 2638 when the medicine container 12 is inserted into the support wall 38.
As shown in Figure 7, when the drug container 12 is positioned by a pair of front support walls 2636 and a rear support wall 2638, a gap S1 is secured between the sealing sheet 18 or peel-off film 20 that forms the back surface of the drug container 12 and the front surface 2602B of the rear wall 2602, allowing air to flow through.

As shown in FIG. 11, upper side surfaces 2636C of the pair of front support walls 2636 are formed so as to be able to abut against both left and right sides of the bulge portion 1604 from the left and right outside of the case 14.
Therefore, the support wall 38 that supports the medicine container 12 so that it can be inserted and removed from both the left and right sides of the case 14 is composed of a pair of front support walls 2636 in the front-rear direction.
As shown in Figures 9 and 14, although the dimensions of the upper side surfaces 2636C of a pair of front support walls 2636 in the longitudinal direction that protrude above the intermediate upright wall 2626 are slightly larger than the width of the bulging portion 1604 of the drug container 12, the upper side surfaces 2636C of the pair of front support walls 2636 in the longitudinal direction function to position the bulging portion 1604 of the drug container 12 between these upper side surfaces 2636C, thereby positioning the drug container 12 in the left-right direction of the case 14.
That is, the support wall 38, which is provided on the container body 26 above the bottom wall 2620 and away from the rear wall 2602 and supports the drug container 12 so that it can be inserted and removed from below, both sides of the case 14 in the front-to-back direction, and both sides of the case 14 in the left-to-right direction, is composed of a support wall 2628 for the bulge portion, a pair of front-to-back front support walls 2636, and a rear front-to-back support wall 2638.

In addition, the upper parts of the pair of front-to-back support walls 2636 that protrude above the intermediate upright wall 2626 and the bulge support wall 2628 also function to contact the lower part of the bulge 1604 and correct the drug container 12 to the correct insertion position when the drug container 12 is tilted from the normal insertion position (the position in which the drug container 12 is positioned in the up-down, front-to-back, and left-to-right directions of the case 14 by the bulge support wall 2628, the pair of front-to-back front support walls 2636, and the front-to-back rear support wall 2638) when inserting the drug container 12 into the support wall 38, which is advantageous for smooth insertion of the drug container 12 into the support wall 38.
In addition, the support wall 2628 for the bulge portion functions as a marker for indicating where to position the bulge portion 1604 when inserting the drug container 12 into the support wall 38, which is advantageous for smoothly inserting the drug container 12 into the support wall 38.

As shown in Figures 9 and 14, a pair of wall portions 2640 having the same thickness as the pair of front support walls 2636, including the lower ends of the pair of front support walls 2636, rise from the bottom wall 2620 and extend between the rear wall 2602 and the intermediate rising wall 2626, connecting the rear wall 2602 and the intermediate rising wall 2626.
The pair of walls 2640 also function as ribs that increase the rigidity of the bottom wall 2620 , the pair of lower side walls 2622 , and the intermediate upright wall 2626 .
The height of the pair of wall portions 2640 from the bottom wall 2620 is dimensioned so that when the drug container 12 is supported by the bulge support wall 2628, the lower end of the outer flange 1602 of the drug container 12 is positioned at a distance above the pair of wall portions 2640.
Therefore, as shown in Figures 3 and 14, when the drug container 12 is supported by the support wall 2628 for the bulge portion, a gap is secured between the lower edge of the outer flange 1602 of the drug container 12 and the bottom wall 2620, allowing air to flow through.

As shown in FIGS. 12 and 13, a clip 30 is provided at the center of a rear surface 2602A of the rear wall 2602, which is detachably attached to a wind direction plate 3402 arranged in the air outlet 34 as shown in FIG.
The clip 30 may be provided on the upper or lower part of the rear wall 2602, or on the container body 26 including the bottom wall 2620, but in this embodiment, the clip 30 is provided in the center of the rear wall 2602 so that the case 14 can be attached to the air deflector 3402 in a stable manner.
As shown in Figures 21 (A) and (B), the clip 30 has a rectangular base 3002 and a pair of arm portions 3004 protruding from the base 3002, and is configured to clamp the air deflector 3402 between the pair of arm portions 3004.
The base 3002 is provided with a protrusion 3006 that is pressed into the clip fitting hole 2604 , and the clip 30 is attached to the rear wall 2602 by pressing the protrusion 3006 into the clip fitting hole 2604 .
In this embodiment, the up-down direction of the chemical volatilizer 10 in use is determined. Therefore, as shown in Figures 12, 13, and 15, when the clip 30 clamps the airflow direction plate 3402 and the chemical volatilizer 10 is placed in the air outlet 34, a pair of stopper walls 2642 that abut against the base 3002 of the clip 30 and restrict the rotation range of the clip 30 are provided on the back surface 2602A of the back wall 2602 so that the up-down direction of the chemical volatilizer 10 is determined.
With the rear wall 2602 attached to the airflow direction plate 3402 by the clips 30, the rear wall 2602 is positioned on a plane extending in the vertical direction.

As shown in Figures 13 and 15, an adjustment member support wall 40 that rotatably supports the adjustment member 32 protrudes around the clip fitting hole 2604 and a pair of stopper walls 2642, on a circumference centered on the axis of the clip fitting hole 2604.
The support wall 40 for the adjustment member is composed of three locking walls 4002 located above the clip fitting hole 2604 and on both sides below the clip fitting hole 2604, and two cylindrical walls 4004 extending in an arc shape on both the left and right sides of the clip fitting hole 2604.
As shown in Figure 13, the engagement wall 4002 has a cylindrical portion 4002A located on the same cylindrical surface as the cylindrical surface of the cylindrical wall 4004, and a claw portion 4002B that protrudes radially outward from the upper end of the cylindrical portion 4002A.
As shown in FIGS. 12, 13 and 15, locking projections 4004A are provided at the ends of the two cylindrical walls 4004 in the extending direction.

As shown in FIG. 12, a rear wall 2602 is provided with an adjustment member 32 that changes the opening area of a pair of variable air intake ports 2606 .
As shown in Figure 22, the adjustment member 32 is composed of a rotating plate 3202 in the shape of a ring plate, with a bearing hole 3204 penetrating through the center, multiple openings 3206 spaced apart circumferentially, and a knob 3208 for rotation operation protruding from the outer periphery.
Three locking recesses 3210 are provided in the inner peripheral edge portions of two opposing locations that form the bearing hole 3204, and are aligned in the circumferential direction and recessed radially outward of the bearing hole 3204.
The adjustment member 32 is attached to the rear wall 2602 by aligning the adjustment member support wall 40 (the three locking walls 4002 and the two cylindrical walls 4004 ) with the bearing hole 3204 and pushing it into the rear wall 2602 .

That is, by placing the adjustment member support wall 40 opposite the bearing hole 3204 and pushing the adjustment member 32 into the rear wall 2602, the three locking walls 4002 bend radially outward from the clip fitting hole 2604, and when the rear wall 2602 passes through the claw portions 4002B, the three locking walls 4002 return to their original positions due to the elasticity of each locking wall 4002, whereby the claw portions 4002B of each of the three locking walls 4002 lock onto the inner peripheral edge of the bearing hole 3204 of the adjustment member 32, and the adjustment member 32 is prevented from coming off the three adjustment member support walls 40, and the bearing hole 3204 is rotatably supported by the cylindrical portions 4002A of the three locking walls 4002 and the two cylindrical walls 4004. That is, the adjustment member 32 is supported by the rear wall 2602 so as to be rotatable around the clip 30.
Furthermore, when the support wall 40 for the adjustment member is placed opposite the bearing hole 3204 and the adjustment member 32 is pushed into the rear wall 2602, the adjustment member 32 is aligned so that the locking protrusion 4004A of the cylindrical wall 4004 fits into the locking recess 3210 on the inner peripheral edge of the bearing hole 3204, and the adjustment member 32 is pushed into the rear wall 2602, whereby the locking protrusion 4004A engages with the locking recess 3210.
As shown in Figures 11, 12, and 20, the rotation operation knob 3208 is arranged on the back surface 2608A of the protruding wall between the upper end wall portion 2616A and the lower end wall portion 2616B, and the adjustment member 32 is rotatably supported on the back surface 2602 within a range in which the rotation operation knob 3208 can swing between the upper end wall portion 2616A and the lower end wall portion 2616B, and the tip of the rotation operation knob 3208 protrudes outside the back surface 2602.

20A , in the rotational position of the adjustment member 32 where the rotation knob 3208 is in contact with the upper end wall portion 2616A, the locking protrusion 4004A locks into the locking recess 3210 at one end of the three locking recesses 3210. In this rotational position of the adjustment member 32, two openings 3206 are positioned for each variable air intake 2606, and therefore, the pair of variable air intakes 2606 has the size of four openings 3206.
20(B), when the adjustment member 32 is rotated to a position where the rotation knob 3208 is positioned midway between the upper end wall portion 2616A and the lower end wall portion 2616B, the locking protrusion 4004A locks into the middle locking recess 3210 of the three locking recesses 3210. In this state, one opening 3206 and half of the opening 3206 are positioned for each variable air intake 2606, and therefore the pair of variable air intakes 2606 has the size of three openings 3206.
20(C), when the adjustment member 32 is rotated to a position where the rotation knob 3208 abuts against the lower end wall portion 2616B, the locking protrusion 4004A locks into the locking recess 3210 at the other end of the three locking recesses 3210. When the adjustment member 32 is rotated to this position, one opening 3206 is positioned for each variable air intake 2606, and therefore, the pair of variable air intakes 2606 has the size of two openings 3206.
By operating the rotation knob 3208 in this manner, the adjustment member 32 rotates, and the opening area of the pair of variable air intakes 2606 can be changed between the size of four openings 3206, the size of three openings 3206, and the size of two openings 3206.

The lid 28 is connected to the container body 26 so as to be swingable between a closed position in which the storage section 36 is closed, as shown in FIG. 3, and an open position in which the storage section 36 is open, as shown in FIGS. 7 and 8.
As shown in Figures 1, 2, and 23, the lid body 28 has a substantially rectangular front wall 2802 that faces the rear wall 2602 when the lid body 28 is in the closed position, and the front wall 2802 has a back surface 2802A that faces the rear wall 2602 and a front surface 2802B that is located opposite the back surface 2802A.
A circular viewing window 2804 is provided in the center of the front wall 2802, through which the top surface 1604B of the bulging portion 1604 of the medicine container 12 can be seen.
As shown in Figure 23, the area around the viewing window 2804 on the back surface 2802A of the front wall 2802 is formed as a bulging wall 2806 that bulges out toward the periphery of the top surface 1604A of the bulging portion 1604 of the drug container 12 positioned within the storage section 36 by the support wall 38.

A pair of support pieces 2808 protrude from both the left and right sides of the lower part of the back surface 2802A of the front wall 2802, and the support pieces 2808 are provided with support shaft holes 2810 that rotatably support the support shafts 2634 of the container body 26.
Therefore, by bending the front wall 2802 and bringing the lower part of the front wall 2802 closer to the pair of side upright walls 2630 of the container body 26, and pushing the pair of support pieces 2808 onto the pair of support shafts 2634 from the inside of the pair of support shafts 2634, the pair of support shafts 2634 are rotatably coupled to the support shaft holes 2810 of the pair of support pieces 2808, as shown in Fig. 9. When removing the lid 28 from the container body 26, the lid 28 can be removed from the container body 26 by performing the above-mentioned operation in reverse.
As shown in FIG. 7, the lid 28 is in the open position when the lower end of the front wall 2802 abuts against the lower end of the intermediate upright wall 2626 of the container body 26.

As shown in Figure 23, the cover body 28 further has an upper wall 2812 protruding from the upper edge of the outer periphery of the back surface 2802A of the front wall 2802, and a pair of upper side walls 2814 connected to the upper wall 2812 and protruding from the left and right side edges of the back surface 2802A of the front wall 2802.
The top wall 2812 and the pair of upper side walls 2814 form part of the peripheral wall 1402 .
As shown in Figures 1 and 28, an arrow 2816 is provided on the surface of the upper wall 2812 as a mark to remind the user of the direction in which to swing the lid 28 to the open position when opening the lid 28.
As shown by the imaginary lines in Figure 14, the inner surface 2812A of the upper wall 2812 forms a regulating portion 42 that abuts against the outer flange 1602 of the drug container 12 when the drug container 12 attempts to move upward from the state supported by the support wall 38 when the lid body 28 is in the closed position, thereby regulating (preventing) the upward movement of the drug container 12.
Therefore, the regulating portion 42 is designed to maintain a state in which the drug container 12 is supported from both the front and rear sides of the case 14 by a pair of front-to-rear support walls 2636 and a pair of rear-to-rear support walls 2638, and a state in which the bulge portion 1604 of the drug container 12 is supported from both the left and right sides of the case 14 by the side surfaces 2636C of the pair of front-to-rear support walls 2636.
As shown in FIG. 23, a plurality of protrusions 2818 that engage with and disengage from a locking plate 2618 on the rear wall 2602 are provided on the tip of an inner surface 2812 A of the upper wall 2812 .

When the lid body 28 is pivoted from the open position to the closed position, for example, by pinching the pair of upper side walls 2814 with one hand, the locking plate 2618 bends, causing the upper end of the locking plate 2618 to climb over the multiple protrusions 2818, and the lid body 28 moves to the closed position. When the upper end of the locking plate 2618 climbs over the multiple protrusions 2818, the user feels a click.
Furthermore, when the lid body 28 is swung from the closed position to the open position, for example, by pinching the pair of upper side walls 2814 with one hand, the locking plate 2618 bends, causing the upper end of the locking plate 2618 to climb over the multiple protrusions 2818, and the lid body 28 moves to the open position. When the upper end of the locking plate 2618 climbs over the multiple protrusions 2818, the user feels a clicking sensation.
As will be described later, as shown in Figures 3 and 4, when the lid body 28 is in the closed position, the left and right sides of the lower part of the back surface 2802A of the front wall 2802 abut against the tip wall 2630A of the container body 26, preventing the upper wall 2812 from swinging toward the back surface 2602, and multiple protrusions 2818 prevent the upper wall 2812 from swinging away from the back surface 2602, so that the closed position of the lid body 28 is maintained.

As shown in FIGS. 23 to 25, the pair of upper side walls 2814 are provided on the rear surface 2802 A of the front wall 2802 from the upper part to the middle part of the side edges on both the left and right sides.
As shown in Figures 23, 24, and 27, a notch 2820 is provided in the rear portion of one of the pair of upper side walls 2814, opposite the front wall 2802, and an engagement recess 2822 is provided at the top of the notch 2820.
As shown in FIGS. 23, 25, and 27, a notch 2824 is provided in the rear portion of the other of the pair of upper side walls 2814, which is positioned opposite the front wall 2802.
As shown in Figure 3, when the lid body 28 is in the closed position, the lower edge of one of the upper side walls 2814 fits into the upper edge of one of the pair of lower side walls 2622 of the container body 26, and the engagement recess 2822 fits into the wall surface of the back wall 2602 that borders the upper part of one of the pair of air intake notches 2624 of the container body 26, and the air intake notch 2624 and the notch 2820 of one of the upper side walls 2814 form a first lateral air outlet 44A.

Also, as shown in Figure 4, when the lid body 28 is in the closed position, the lower edge of the other upper side wall 2814 fits with the upper edge of the other lower side wall 2622 of the pair of lower side walls 2622 of the container body 26, and the rear edge of the other upper side wall 2814 located above the air intake notch 2624 fits with the wall surface of the back wall 2602 that borders the upper part of the other air intake notch 2624 of the pair of air intake notches 2624 of the container body 26, and the air intake notch 2624 and the notch 2824 of the other upper side wall 2814 form a second lateral air outlet 44B.
Furthermore, as shown in Figures 3 and 4, when the lid body 28 is in the closed position, the left and right sides of the lower part of the back surface 2802A of the front wall 2802 abut against the tip wall 2630A of the container body 26, and the lower edges of the pair of upper side walls 2814 meet the upper edges of the pair of lower side walls 2622 of the container body 26, and as shown in Figure 6, a horizontally elongated rectangular downward air outlet 44C is formed by the lower edge of the front wall 2802, the intermediate upright wall 2626 of the container body 26, and the pair of side upright walls 2630.

Furthermore, as shown in Figure 20 (A), when the lid body 28 is in the closed position, the curved connection portions between the upper wall 2812 and a pair of upper side walls 2814 are located above a pair of air intake notches 2610 in the rear wall 2602 of the container body 26, and a pair of fixed air intake ports 46 extending in an arc are formed by the pair of air intake notches 2610 and the curved connection portions.
Furthermore, as shown in Figures 3 and 14, when the cover 28 is in the closed position and the drug container 12 is supported by the bulge support wall 2628, the pair of front support walls 2636 in the longitudinal direction, and the rear support wall 2638 in the longitudinal direction, a gap S2 is secured between the entire circumference of the outer flange 1602 of the drug container 12 and the peripheral wall 1402, allowing air to flow. Also, a gap S3 is secured between the outer flange 1602 of the drug container 12 and the front wall 2802, allowing air to flow. Since the front wall 2802 and the top surface 1604B of the bulge 1604 are separated in the longitudinal direction, the gap S3 is connected to the viewing window 2804 (see Figure 2), and the viewing window 2804 forms the front air outlet 44D.

Next, the method of use, action, and effect of the medicine volatilizing device 10 of this embodiment will be described.
When the drug volatilizer 10 is shipped, the drug container 12 is inserted into the support wall 38 with the release film 20 facing the rear wall 2602, with the tabs 1606, 1804, and 2004 folded from the cut lines to the upper end of the release film 20, and the drug container 12 is positioned in the up-down, front-back, and left-right directions of the case 14 with the lid 28 in the closed position.In this state, the drug container 12 is shipped, for example, in a packaging bag or a packaging box.
In this case, when inserting the drug container 12 into the support wall 38, the bent tabs 1606, 1804, 2004 will not come into contact with any part of the inside of the case 14 regardless of whether they are positioned above, below, or to the left or right side, thereby ensuring smooth insertion of the drug container 12.

When using the drug volatilizer 10, the user changes the lid 28 from the closed position to the open position as shown in Figure 8, removes the drug container 12 from the support wall 38 as shown in Figure 9, breaks the tabs 1606, 1804, and 2004 along the cutting lines, and pinches the tabs 1606, 1804, and 2004 to peel the release film 20 from the sealing sheet 18.
Then, as shown in FIG. 8, the outer peripheral flange 1602 of the medicine container 12 is inserted between the support walls 38 with the sealing sheet 18 facing the rear wall 2602, and the lid 28 is moved from the open position to the closed position.
In this case, the medicine container 12 may be arranged such that the bulging base portion 1602A is located at any position above, below, or on the left or right side.
Then, as shown in FIG. 1, the airflow direction plate 3402 arranged at the air outlet 34 is clamped with the clip 30, and the medicine volatilizer 10 is arranged with the rear wall 2602 facing the air outlet 34.
When the release film 20 is peeled off from the sealing sheet 18, the drug 22 in contact with the sealing sheet 18 penetrates the sealing sheet 18 and volatilizes from the surface of the sealing sheet 18, and the drug 22 volatilizes into the space above the drug containing space 24, penetrates the sealing sheet 18 from the upper space and volatilizes.

As shown in Figure 20 (A), some of the air blown out from the air outlet 34 enters the inside of the case 14 through the pair of fixed air intakes 46 and the variable air intake 2606 and the gap S1 shown in Figure 7, where it hits the sealing sheet 18.The air that entered the gap S1 from the variable air intake 2606 is blown into the vehicle cabin together with the volatilized chemical 22 from the first side air outlet 44A shown in Figure 3, the second side air outlet 44B shown in Figure 4, and the downward air outlet 44C shown in Figure 6, and the fragrance is diffused throughout the vehicle cabin.
Furthermore, as shown in Figures 3 and 14, the air containing the evaporated chemical 22 flows from the gap S2 between the periphery of the sealing sheet 18 and the peripheral wall 1402 to the gap S3 between the front wall 2802 and the outer flange 1602 of the chemical container 12, and is blown out through the viewing window 2804 into the vehicle cabin, diffusing the fragrance into the vehicle cabin.
As the drug volatilizer 10 is used, the amount of drug 22 gradually decreases, and as shown in Figure 2, the liquid level H of the drug 22 located on the top surface 1604B visible from the visual inspection point gradually decreases, and when the liquid level H of the drug 22 reaches zero, the drug container 12 is replaced.

To replace the drug 22, the cover 28 is swung from the closed position to the open position.
In this case, when the lid 28 is swung from the closed position to the open position with one hand as described above, the locking plate 2618 bends, causing the upper end of the locking plate 2618 to climb over the multiple protrusions 2818, and the lid 28 swings to the open position.When the lid 28 is in the open position, the storage section 36 is opened and approximately two-thirds of the drug container 12, excluding the lower end, is visible, so the drug container 12 can be removed upward from the storage section 36 by grasping both sides of the upper part of the outer flange 1602 of the drug container 12 with one hand.
Then, a new medicine container 12 from which the release film 20 has been peeled off is inserted into the container section 36, and the lid 28 is swung from the open position to the closed position with one hand, allowing the medicine volatilizer 10 to be used repeatedly.

Therefore, according to this embodiment, with the container body 26 attached to the air deflector 3402 of the air outlet 34 by the clip 30, the lid body 28 can be easily swung from the closed position to the open position and from the open position to the closed position with one hand.
Also, as shown in Figures 7 and 8, when the lid 28 is in the open position, most of the drug container 12 contained in the storage section 36, except for the lower end, is exposed behind the lid 28 in front of the rear wall 2602.
Therefore, by grasping the outer peripheral flange 1602 of the drug container 12 with one hand, the drug container 12 can be easily removed upward from the storage section 36 and inserted into the storage section 36 from above, and the drug container 12 can be easily replaced with one hand, which is advantageous in increasing the commercial value of the drug volatilizer 10, increasing purchasing desire for the drug volatilizer 10, and increasing the purchase volume of the drug volatilizer.
Furthermore, the clip 30 may be attached to the top, bottom, left or right side of the lid body 28, but if the clip 30 is attached to the container body 26 as in this embodiment, the drug container 12 can be replaced without removing the drug volatilizer 10 from the air deflector 3402, which is advantageous in increasing the commercial value of the drug volatilizer 10, increasing purchasing desire for the drug volatilizer 10, and increasing the amount of drug volatilizers purchased.

In addition, the container body 26 is configured to include support walls 38 that support the drug container 12 so that it can be inserted and removed from below, both sides of the case 14 in the front-to-back direction, and both sides of the case 14 in the left-to-right direction.Therefore, by inserting the drug container 12 from above the storage section 36, the drug container 12 can be easily positioned relative to the storage section 36, which improves the usability of the drug volatilizer 10, increases the commercial value of the drug volatilizer 10, increases purchasing desire for the drug volatilizer 10, and is advantageous in increasing the amount of drug volatilizers purchased.
Furthermore, since the drug container 12 is supported by the support wall 38 with the sealing sheet 18 facing the rear wall 2602, air from the air outlet 34 that passes through the variable air intake 2606 in the rear wall 2602 hits the sealing sheet 18, which is advantageous in effectively exerting the aromatic and deodorizing effects of the drug volatilizer 10.

The support wall 38 that supports the medicine container 12 from below is composed of a bulging portion support wall 2628 that supports the bulging portion 1604 from below.
Therefore, when inserting the drug container 12 into the support wall 38, the support wall 2628 for the bulge portion functions as a marker for indicating where to position the bulge portion 1604, which is advantageous for smoothly inserting the drug container 12 into the support wall 38.
In addition, the support walls 38 that support the drug container 12 from both sides of the case 14 in the front-to-back direction are composed of a pair of front-to-back front support walls 2636 that abut from the front of the case 14 against the outer peripheral flanges 1602 located on both the left and right sides of the bulge portion 1604, and a rear-to-back support wall 2638 that abuts the drug container 12 from the rear of the case 14, and the support walls 38 that support the drug container 12 from both sides of the case 14 in the left-to-right direction are composed of a pair of front-to-back support walls 2636.
In other words, the pair of front-to-rear support walls 2636 are used as walls that position the case 14 of the drug container 12 in the front-to-rear direction, and at the same time, by arranging the pair of front-to-rear front support walls 2636 so that they can abut against the left and right sides of the bulge portion 1604, they are used as walls that position the case 14 in the left and right direction, which is advantageous in simplifying the structure of the support walls 38 and in reducing the cost of the case 14.

Furthermore, when the lid body 28 is in the closed position, the lid body 28 has a front wall 2802 that faces the rear wall 2602 and has a viewing window 2804 formed therein, and an upper wall 2812 that protrudes from the upper end of the front wall 2802, faces the bottom wall 2620, and has its tip joined to the upper end of the rear wall 2602. The upper wall 2812 is provided with a regulating section 42 that regulates the upward movement of the drug container 12 supported by the support wall 38. This is advantageous in stabilizing the posture of the drug container 12 supported by the support wall 38 and contained in the container section 36 when the lid body 28 is in the closed position, and is advantageous in increasing the commercial value of the drug volatilizer 10.
Furthermore, when lid 28 is in the closed position, case 14 includes peripheral wall 1402 that connects the periphery of rear wall 2602 and the periphery of front wall 2802 and forms first side air outlet 44A (see FIG. 3), second side air outlet 44B (see FIG. 4), and lower air outlet 44C (see FIG. 6). A gap S1 (see FIG. 7) that allows air to circulate is secured between medicine container 12 supported by support wall 38 and rear wall 2602, and the periphery of medicine container 12 and peripheral wall 1402 are spaced apart. 02, a gap S2 (see Figure 14) is secured between the drug container 12 and the variable air intake 2606, which allows air to circulate around the entire periphery of the drug container 12. This is advantageous in that more air from the air outlet 34 can be taken into the inside of the case 14 through the variable air intake 2606, which is advantageous in fully exerting the effects of the drug 22, such as its aromatic and deodorizing effects, which is advantageous in increasing the commercial value of the drug volatilizer 10, increasing purchasing desire for the drug volatilizer 10, and increasing the amount of drug volatilizers purchased.
Furthermore, when the lid body 28 is in the closed position, a gap S3 (see Figure 3) is secured between the front wall 2802 and the outer peripheral flange 1602, which allows air to circulate through the viewing window 2804. This allows air containing the vaporized chemical 22 to be blown out through the viewing window 2804, which is advantageous in that more air from the air outlet 34 can be taken in through the variable air intake 2606 into the case 14, which is advantageous in fully exerting the effects of the chemical 22, such as its aromatic and deodorizing effects, which is advantageous in increasing the commercial value of the chemical volatilizer 10, increasing purchasing desire for the chemical volatilizer 10, and increasing the purchase volume of the chemical volatilizer.

Furthermore, as shown in Figure 20, an adjustment member 32 is provided to change the opening area of the variable air intake 2606. For example, if an air freshener or deodorizer is used as the chemical 22, and a stronger fragrant or deodorizing effect is desired, the opening area can be increased to allow more air to enter the case 14, thereby enhancing the fragrant or deodorizing effect.
Furthermore, for example, if one wishes to extend the life of the drug container 12 or to suppress the aromatic or deodorizing effects, the opening area of the variable air intake 2606 can be reduced using the adjustment member 32, thereby reducing the amount of air entering the case 14, thereby allowing the drug container 12 to be used for a long period of time and suppressing the aromatic or deodorizing effects.
Therefore, it is advantageous in increasing the commercial value of the medicine volatilizer 10, increasing the willingness to purchase the medicine volatilizer 10, and increasing the amount of medicine volatilizers purchased.
Furthermore, the clip 30 is positioned approximately in the center of the rear wall 2602, and the adjustment member 32 is positioned so that it can rotate around the clip 30. As a result, when viewed from the front of the drug volatilizer 10, all of the remaining adjustment members 32 except for the rotation control knob 3208 are hidden by the case 14, which enhances the design of the drug volatilizer 10, which has the function of adjusting the opening area of the variable air intake 2606, increases purchasing desire for the drug volatilizer 10, and is advantageous in increasing the purchase volume of drug volatilizers.

10 Medicine volatilizer 12 Medicine container 14 Case 1402 Peripheral wall 16 Container body 1602 Outer peripheral flange 1602A Bulging base 1604 Bulging portion 1604A Side surface 1604B Top surface 1606 Handle piece 18 Sealing sheet 1802 Rectangular portion 1802A Bulging base 1804 Handle piece 20 Release film 2002 Rectangular portion 2002A Bulging base 2004 Handle piece 22 Medicine 24 Medicine container space 26 Container body 2602 Back wall 2602A Back surface 2602B Front surface 2604 Clip fitting hole 2606 Variable air intake port 2608 Protruding wall 2608A Protruding wall back surface 2610 Air intake notch 2612 Cylindrical upright surface 2614 Upright surface 2616A continuing from the cylindrical upright surface, upper end wall portion 2616B, lower end wall portion 2618, locking plate 2620, bottom wall 2622, lower side wall 2624, air intake notch 2626, intermediate upright wall 2628, bulge support wall 2630, side upright wall 2630A, tip wall 2632, lower notch 2634, support shaft 2636, front-to-rear direction front support wall 2636A, rear surface 2636B, curved surface 2636C, side surface 2638, front-to-rear direction rear support wall 2638A, front surface 2638B, inclined surface 2640, wall portion 2642, stopper wall 28, lid 2802, front wall 2802A, rear surface 2802B, front surface 2804, viewing window 2806, bulge wall 2808, support piece 2810 Hole for support shaft 2812 Top wall 2812A Inner surface 2814 of top wall Upper side wall 2816 Arrow 2818 Protrusion 2820 Notch 2822 Engagement recess 2824 Notch 30 Clip 3002 Base 3004 Arm 3006 Protrusion 32 Adjustment member 3202 Rotating plate 3204 Bearing hole 3206 Opening 3208 Rotation operation knob 3210 Locking recess 34 Air outlet 3402 Air direction plate 36 Storage section 38 Support wall 40 Adjustment member support wall 4002 Locking wall 4002A Cylindrical section 4002B Claw section 4004 Cylindrical wall 4004A Locking protrusion 42 Regulating section 44A First side air outlet 44B Second side air outlet 44C Downward air outlet 44D Front air outlet 46 Fixed air intakes S1, S2, S3 Gap H Liquid level

Claims (8)

A drug volatilization device comprising a drug container in which a drug is enclosed and a case for accommodating the drug container, the case being attached to an air outlet of an air conditioner,
The drug container comprises a container body formed of a transparent material that is impermeable to the drug, the container body having an outer peripheral flange extending in a frame shape on a plane and a bulging portion that bulges out hollowly from the inside of the outer peripheral flange; a sealing sheet formed of a material that allows the drug to pass through and attached to the outer peripheral flange, closing the bulging portion and sealing the drug inside the bulging portion; and a release film formed of a material that is impermeable to gas and the drug and releasably attached to the sealing sheet.
The case includes a container body having a storage section for storing the medicine container and attached to the air outlet, and a lid body coupled to the container body so as to be swingable between a closed position for closing the storage section and an open position for opening the storage section, the lid body having a viewing window through which the medicine sealed in the bulge section can be viewed when the lid body is positioned at the closed position,
When the container body is attached to the air outlet, and the air blowing direction of the air outlet is defined as the forward direction and the opposite direction as the backward direction, the container body, when attached to the air outlet, has a rear wall facing the air outlet and having an air intake, a bottom wall protruding forward from the lower end of the rear wall, and an intermediate upright wall standing upward from the front end of the bottom wall,
When the container body is attached to the air outlet, the storage section includes a support wall that supports the medicine storage body so that the medicine storage body can be removed from and inserted into the container body when the lid is in an open position,
the medicine container is supported by the support wall with the sealing sheet or the release film facing the rear wall,
When the container body is attached to the air outlet, the support wall is configured to include a bulge portion support wall that protrudes forward in an arc shape from an upper edge of the intermediate upright wall, on which the bulge portion is placed and that supports the bulge portion from below.
A drug volatilization device characterized by: The container body is provided with a clip that can be detachably attached to a wind direction plate disposed at the air outlet.
2. The drug volatilizer according to claim 1. When the container body is attached to the air outlet, the support wall is provided on the container body, above the bottom wall and at a position spaced forward from the rear wall, and supports the medicine container so as to be insertable and detachable from below, both sides in the front-rear direction of the case, and both sides in the left-right direction of the case,
The support wall that supports the medicine container from below is formed by the support wall for the bulge portion.
2. The drug volatilizer according to claim 1 . the support walls supporting the medicine container from both sides in the front-rear direction of the case are composed of a pair of front-rear direction front support walls abutting the outer peripheral flanges located on both the left and right sides of the bulging portion from the front of the case, and a pair of front-rear direction rear support walls abutting the medicine container from the rear of the case,
the pair of front support walls are provided to be able to abut against the outer peripheral flanges located on both the left and right sides of the bulging portion from the front of the case,
The front -rear direction rear support wall is provided so as to be able to abut against the sealing sheet or the release film from the rear of the case.
4. The drug volatilizer according to claim 3. the lid body has a front wall that faces the rear wall when the lid body is positioned at the closed position and in which the viewing window is formed, and an upper wall that projects rearward from an upper end of the front wall, faces the bottom wall in the closed position, and has a tip that fits into an upper end of the rear wall,
a restricting portion provided on the upper wall for restricting upward movement of the medicine container supported by the support wall;
2. The drug volatilizer according to claim 1 . the case includes a peripheral wall that connects the periphery of the rear wall and the periphery of the front wall and forms an air outlet when the lid is in the closed position,
the bottom wall and the top wall constitute a part of the peripheral wall,
When the lid body is positioned at the closed position, a gap that allows air to pass between the medicine container supported by the support wall and the rear wall is secured, and a gap that allows air to pass around the entire circumference of the medicine container is secured between the periphery of the medicine container and the peripheral wall.
6. The drug volatilizer according to claim 5 . When the cover is in the closed position, a gap is secured between the front wall and the outer peripheral flange to allow air to circulate and to communicate with the viewing window.
6. The drug volatilizer according to claim 5 . a clip that can be detachably attached to a wind direction plate disposed at the air outlet is provided at approximately the center of the rear wall;
An adjustment member that changes the opening area of the air intake port is disposed on the rear wall and is rotatable around the clip.
2. The drug volatilizer according to claim 1 .